Tumor volume determines the feasibility of cell-free DNA sequencing for mutation detection in non-small cell lung cancer.
about
Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancerThe emerging roles of NGS-based liquid biopsy in non-small cell lung cancer.Proof of concept: prognostic value of the plasmatic concentration of circulating cell free DNA in desmoid tumors using ddPCR.
P2860
Tumor volume determines the feasibility of cell-free DNA sequencing for mutation detection in non-small cell lung cancer.
description
2016 թվականի օգոստոսի 30-ին հրատարակված գիտական հոդված
@hy
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
Tumor volume determines the fe ...... in non-small cell lung cancer.
@en
Tumor volume determines the fe ...... in non-small cell lung cancer.
@nl
type
label
Tumor volume determines the fe ...... in non-small cell lung cancer.
@en
Tumor volume determines the fe ...... in non-small cell lung cancer.
@nl
prefLabel
Tumor volume determines the fe ...... in non-small cell lung cancer.
@en
Tumor volume determines the fe ...... in non-small cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Tumor volume determines the fe ...... in non-small cell lung cancer.
@en
P2093
Jun Matsubayashi
Junichi Maeda
Kazuko Sakai
Kazuto Nishio
Keishi Ohtani
Koichi Yoshida
Masaaki Hibi
Masaru Hagiwara
Masatoshi Kakihana
Naohiro Kajiwara
P2860
P304
P356
10.1111/CAS.13068
P577
2016-08-30T00:00:00Z